Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 13,448 | 14,753 | 13,621 | 12,762 | 12,570 |
| Operating Income | -13,448 | -14,753 | -13,621 | -12,762 | -12,570 |
| Other Income | -60,548 | 133 | 187 | 281 | -15 |
| Pre-tax Income | -73,996 | -14,620 | -13,434 | -12,481 | -12,585 |
| Net Income Continuous | -73,996 | -14,620 | -13,434 | -12,481 | -12,585 |
| Net Income | $-73,996 | $-14,620 | $-13,434 | $-12,481 | $-12,585 |
| EPS Basic Total Ops | -64.47 | -13.49 | -11.99 | 203.90 | -19.49 |
| EPS Basic Continuous Ops | -65.02 | -13.63 | -12.54 | -12.29 | -13.36 |
| EPS Diluted Total Ops | -64.47 | -13.49 | -11.99 | 203.90 | -19.49 |
| EPS Diluted Continuous Ops | -65.02 | -13.63 | -12.54 | -12.21 | -13.36 |
| EBITDA(a) | $-13,291 | $-14,597 | $-13,481 | $-12,599 | $-12,413 |